What the research says about matcha
The research on matcha is promising but thin. Most human evidence covers green tea generally rather than matcha, and the strongest matcha-specific findings are small, short-term effects on attention and stress in trials of a few dozen people. Bigger claims about burning fat, detoxing or preventing disease are not established.
What is the overall picture from matcha research
A 2022 critical review in Current Research in Food Science looked at the human and animal studies on matcha specifically and reached a deliberately modest conclusion. Randomised trials, it reported, suggest matcha decreases stress, slightly enhances attention and memory, and has no effect on mood, while results on cognitive function overall are contradictory. On cardio-metabolic effects it noted the work has only been done in animals, and on anti-tumour effects the evidence is very limited. Its summary was that conclusions cannot yet be drawn.
That is the honest starting point for everything below. Three separate things get blurred together in matcha marketing: laboratory findings about isolated compounds, observational associations among green tea drinkers, and the handful of controlled trials that fed people actual matcha. They carry very different weight, and this page keeps them apart.
What do trials say about matcha, alertness and stress
This is where the matcha-specific evidence is strongest, and it is still small. A 2017 randomised, placebo-controlled trial of 23 people published in Food Research International gave matcha as a drink and as a snack bar, and reported improvements in basic attention and psychomotor speed with no change in mood on the standard mood questionnaire. The authors described the effects as slight.
Two 2021 trials by the same Japanese group point the same way. In 42 young adults given 2 g of matcha daily for two weeks, reaction times on a Stroop attention test after a mild stress task were significantly lower than placebo. In 51 adults aged 50 to 69 taking matcha, caffeine or placebo for 12 weeks, the matcha group produced more work output on stress tasks, and the authors concluded that matcha with caffeine appeared to improve attention and work performance under psychological stress compared with caffeine alone.
Longer and larger studies are more sober. A 12 week trial in 54 community-dwelling older adults found a cognitive-screening improvement in the women in the active group but not the men. A 12 month randomised trial in 99 older adults with cognitive decline, the longest matcha trial published, found no significant difference on its primary measures of general cognition and daily functioning, with an improvement on a facial-emotion perception score and a non-significant trend on sleep quality.
The mechanism usually credited is L-theanine working alongside caffeine. A 2025 systematic review and meta-analysis in Nutrition Reviews pooled 50 randomised trials of tea, L-theanine and L-theanine plus caffeine and found small to moderate improvements on attention tasks for the combination, while noting that confidence intervals frequently highlighted the uncertainty around the direction and size of those differences. Calm alertness is a plausible and partly supported effect, not a demonstrated one.
What are catechins and EGCG
Catechins are the main polyphenols in green tea, and epigallocatechin gallate, usually shortened to EGCG, is the most abundant and the most studied. They are the compounds behind almost every antioxidant claim made for matcha, and behind most of the green tea trials in the sections below.
Matcha is a concentrated source of them because you swallow the milled leaf instead of steeping it and discarding it. A 2020 review in Molecules puts the caffeine content of matcha at 18.9 to 44.4 mg per gram of powder against 11.3 to 24.67 mg per gram for other green teas, and describes shading during growth as increasing the accumulation of theanine, caffeine, chlorophyll and catechins in the leaf.
Concentration is not the same as effect. Being richer in a compound tells you what is in the cup; it does not tell you what the compound does at that dose in a person, which is exactly what the trials are for.
What does the evidence say about green tea and heart health
This is the largest body of evidence, and it is about green tea rather than matcha. A 2023 meta-analysis of seven prospective cohort studies covering 772,922 participants and 9,211 coronary heart disease cases found a non-linear association, with relative risks compared with non-drinkers of 0.89 at one cup a day, 0.84 at two, 0.85 at three and 0.88 at four, and no significant association among the heaviest drinkers. The authors concluded green tea consumption may be associated with reduced risk, especially at low to moderate intake, and that more cohorts are needed before drawing a firm conclusion.
The best known single cohort points the same way. The Ohsaki study, published in JAMA in 2006, followed 40,530 Japanese adults and reported lower all-cause and cardiovascular mortality among those drinking five or more cups a day compared with less than one, with no reduction in cancer mortality. Cohort studies of this kind can show that tea drinkers differ from non-drinkers; they cannot show that the tea is the reason, because diet, activity and everything else that travels with a tea-drinking habit travel with it into the results.
Controlled trials of intermediate markers are more modest again. A 2014 meta-analysis of randomised trials found green tea consumption changed systolic blood pressure by about 2.08 mmHg and diastolic by about 1.71 mmHg, with the effect possibly larger in people whose systolic pressure was already 130 mmHg or above. A 2011 meta-analysis of 20 trials in 1,415 people, using catechin doses of 145 to 3,000 mg a day, found reductions of roughly 5.46 mg per decilitre in total cholesterol and 5.30 in LDL cholesterol, with no significant effect on HDL or triglycerides. These are real but small shifts in numbers, measured mostly with supplements rather than bowls of tea.
What does the research say about matcha and weight
Short answer: small effects, usually at supplement doses, and nothing that works on its own. The Cochrane review of green tea preparations for weight loss pooled randomised trials in overweight and obese adults and concluded that green tea preparations appear to induce a small, statistically non-significant weight loss, and that because the amount is small it is not likely to be clinically important. It also found no significant effect on maintaining weight loss.
The metabolic mechanism is real but modest. A respiration-chamber meta-analysis found that catechin and caffeine mixtures raised 24 hour energy expenditure by about 428 kJ, roughly 5 per cent, with a similar rise from caffeine alone, and that 24 hour fat oxidation increased only with the catechin and caffeine combination. A single 12 week randomised trial that paired 625 mg of catechins a day with supervised exercise found abdominal fat fell further in the catechin group, while the difference in total body weight did not reach statistical significance.
Note the dose. That trial used 625 mg of catechins a day; the 12 week matcha trial described above delivered about 170 mg of catechins from roughly 2 g of matcha. Much of the metabolic literature is testing concentrated extracts at intakes a normal serving does not reach, which is one of the most common reasons a study headline does not transfer to a cup.
- Does matcha burn belly fat: the same evidence read against the specific claim, including why targeted fat loss is not a thing.
What does the research say about safety
Two separate questions sit here, and conflating them is where most alarming headlines come from. The first is caffeine, which matcha genuinely contains in useful amounts, and which our caffeine guide covers in detail alongside the commonly cited daily ceilings.
The second is concentrated green tea extract. In 2018 the European Food Safety Authority assessed green tea catechins and concluded that doses of 800 mg of EGCG a day or above, taken as a food supplement, were associated with a statistically significant rise in serum transaminases, a marker of liver stress. It treated traditionally prepared green tea infusions differently, considering them in general safe at intakes reported across European member states, while noting rare cases of liver injury after infusions that were most probably an idiosyncratic reaction.
The practical reading of that opinion is that it is an argument about supplements, not about drinking tea. If you have a health condition, are pregnant, or take medication, questions about your own intake are for a health professional rather than a website.
- How much caffeine is in matcha: per-serving figures, comparisons with coffee, and the commonly cited daily limits.
How should you read a matcha study
Most confusion about matcha and health is not caused by bad studies. It is caused by good studies being described as though they were a different kind of study. Five habits do most of the work.
- Check the dose. Many green tea studies use extracts at hundreds of milligrams of catechins a day, well above what one or two servings provide, so the result may not transfer to a cup.
- Check whether it was matcha. A large majority of the literature is green tea generally, and matcha is a more concentrated relative rather than an interchangeable one.
- Check the sample size. The matcha cognition trials run from about 23 to 99 people, which is enough to detect a signal worth following and not enough to settle a question.
- Check the outcome that was measured. Faster reaction times on one attention test are not the same as better memory, and neither is the same as preventing disease.
- Check who is describing it. A press release, a supplement label and the paper's own abstract often say noticeably different things.
| Study type | What it can show | What it cannot show |
|---|---|---|
| Randomised controlled trial | Whether the drink caused the measured change | Much about long-term or rare outcomes from 12 weeks |
| Cohort or observational study | That tea drinkers differ from non-drinkers on an outcome | That the tea caused the difference rather than the lifestyle |
| Cell or test-tube study | That a compound does something in a dish | That drinking a bowl does the same thing in a person |
| Animal study | A mechanism plausible enough to test in people | A human dose, a human effect or a human safety margin |
| Systematic review or meta-analysis | What the pooled body of trials adds up to | More certainty than the underlying trials contain |
Common questions
- Is matcha scientifically proven to be healthy?
- No, not in the strong sense that phrase implies. Reviews of the matcha-specific literature describe small trials with contradictory results and conclude that firm conclusions cannot yet be drawn. Green tea more broadly has been associated with lower coronary heart disease risk in cohort studies, which suggests a link rather than proving cause and effect.
- How many studies are actually about matcha rather than green tea?
- Very few. The matcha-specific human evidence is a small set of randomised trials, mostly Japanese, mostly 12 weeks or shorter, and mostly measuring attention or stress in a few dozen people. Almost everything else quoted about matcha and health is green tea research applied by analogy.
- Does matcha improve focus according to research?
- Trials suggest a small effect. Randomised studies have found faster reaction times on attention tests after matcha, and a 2025 meta-analysis of L-theanine plus caffeine reported small to moderate improvements on attention tasks while stressing the uncertainty around them. A 12 month trial in older adults found no difference on its primary cognitive measures.
- Why do matcha studies use such high doses?
- Because many of them test green tea extracts rather than the drink. Catechin doses of several hundred to a few thousand milligrams a day are common in that literature, while a 12 week matcha trial delivered about 170 mg of catechins from roughly 2 g of powder. High-dose extract results should not be read as results about a bowl of matcha.
- Is green tea extract as safe as drinking matcha?
- Regulators treat them differently. The European Food Safety Authority linked supplement doses of 800 mg of EGCG a day or more to raised liver enzyme markers, while considering traditionally prepared green tea infusions generally safe at reported intakes. That is a reason to be more careful with concentrated extracts than with the drink.